News

During preclinical trials of the toxin, now called ACV1, researchers from Metabolic Pharmaceuticals found it not only to be effective in treating pain in animal models of post-surgical

The drug, Byetta (exenatide) injection is now available for Americans struggling to control type 2 diabetes. Byetta was recently approved by the FDA to help diabetes patients manage

Amyloid A (AA) Amyloidosis is a rare disease that is a consequence of chronic inflammatory diseases like rheumatoid arthritis and familial Mediterranean fever and frequently progresses to end-stage

Tarvacin is a chimeric monoclonal antibody that binds directly to tumor blood vessels to inhibit growth and development of solid tumors. The drug has also shown promise in

The approval follows a positive opinion granted on April 21, 2005, by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA). Temodal

Abatacept is an investigational selective co-stimulation modulator, which, according to new findings from a recent phase III clinical trial, is affective against arthritus independent of baseline clinical, biochemical,

The final data from the phase I trial showed the drug candidate ISIS 301012 to be capable of producing rapid and prolonged reductions of its target, ApoB-100, with

Data from the trial, named ‘Adept’, showed that patients receiving Humira experienced an improvement in quality of life during a 24-week period. Following 24 weeks of treatment, 42%

The trial data indicated that at 18-23 months’ follow-up, there was symptomatic improvement and no safety problems in individuals treated with NX-1207. The symptomatic improvement was determined to